Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Gastrointestinal Agents Market by Type (Dietary Supplements, Drugs), Disease Type (Constipation, Diarrhea, Gastroesophageal Reflux Disease), Route of ...

At present, North America dominates the global gastrointestinal agents market. Particularly U.S. captures the largest market share in the regional gastrointestinal agents market. However, the region ...

A new report from the Agency for Healthcare Research and Quality and the Medical Expenditure Panel Survey has shown that the number of Americans purchasing at least one outpatient prescription ...

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...

A new study published in the American College of Rheumatology journal Arthritis & Rheumatism reveals that not prescribing gastroprotective agents for patients taking COX-2 inhibitors increases the ...

A seismic shift has rocked the foundations of oncology over the past few years, with ground-breaking advances in our understanding of cancer cell biology. The development of a tumor can be the result ...

June 7, 2004 (New Orleans) -- An investigational agent that blocks the tyrosine kinase receptor shows promise as rescue therapy for patients with gastrointestinal stromal tumors (GIST) resistant to ...

The Agency for Healthcare Research and Quality releases statistical briefs with insights on healthcare cost and quality. The following is a list of the top five most costly prescription drugs by total ...

Emerging Technology video presentation describing swine studies using AC5-GTM for submucosal lifting and management of gastrointestinal bleeding in endoscopic resection About Arch Therapeutics, ...